OR WAIT null SECS
June 06, 2019
EMA has opened a three-month consultation on its draft guidelines on the quality of requirements for drug-device combination products.
European midmarket private equity group, Duke Street, has agreed to acquire Kent Pharmaceuticals and Athlone Laboratories from DCC Vital.
June 02, 2019
Excipients and new processing techniques can make a real difference in the development of highly potent therapies.
Exploration of various formulation techniques is vital to provide effective delivery of poorly soluble drugs.
Discussing the advantages, limitations, and recent advances of HME with experts from AbbVie.
A connected MDI may encourage compliance and aid proper technique.
Wearable and smart devices allow user-friendly subcutaneous drug delivery.
May 31, 2019
Prestige BioPharma has announced that the EMA has accepted its marketing authorization application for HD201 (Tuzune) for review.
CDMO, Vibalogics, has revealed that it will be acquired by a private equity firm, Ampersand Capital Partners.
May 30, 2019
Nanobiotix has launched Curadigm, a spinoff company that will specialize in developing a nanotechnology platform for healthcare applications.
